The "Nacimbio" holding (part of the Rostec State Corporation) has developed and started production of the domestic drug "BioGam". It is intended for the therapy of patients with primary and secondary immunodeficiencies. This was reported by the press service of the state corporation.
"BioGam" is included in the list of vital medicines, its production will replace imported analogues on the Russian market. Today, it is the only intravenous human immunoglobulin with a concentration of 10% in Russia.
Drugs in this dosage are crucial for the quality of life of patients with immunodeficiencies. The fact is that a high concentration allows achieving optimal results in the treatment of immunodeficiencies with smaller volumes of the administered drug and in a shorter time.
The first batch of 5 thousand packages will arrive this year. Production volumes are planned to increase in 2025.
Earlier www1.ru reported that "Active Component" by 2025 will build a pharmaceutical substance plant in St. Petersburg.
Read materials on the topic:
New antibiotics will appear in Russia
Russian scientists have created a wine that protects the kidneys from X-ray radiation
Now on home
Герой России Гарнаев: никто из профессионалов о возобновлении производства на КАЗ всерьёз не говорит
Система отслеживает спутники на высотах до 50 000 км и ведёт за ними наблюдение
The armored vehicle is equipped with a KamAZ-740.35-400 diesel engine with a power of 400 hp.
Constant improvements in avionics, weapons and tactical capabilities will make the aircraft a flexible response to future challenges
The exterior of the KamAZ-54901 features fairings on the cab and chassis for fuel economy
Fighters are in demand both domestically and abroad
Tyazhpromexport and Venezuela Agree on Plant Revival
The company not only completed the state order, but also quickly mastered the production of AK-12K for special forces
Experts have developed a photogrammetric complex with a resolution of less than 1 cm
